Janssen Inc. v. Sandoz Canada Inc.
| Jurisdiction | Federal Jurisdiction (Canada) |
| Court | Federal Court (Canada) |
| Citation | 2022 FC 715 |
| Date | 31 May 2022 |
Get this document and AI-powered insights with a free trial of vLex and Vincent AI
Get Started for FreeUnlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Start Your 7-day Trial
6 practice notes
-
UPL NA Inc. v. AgraCity Crop & Nutrition Ltd.
...date and adopt the proper temporal frame of reference to analyze the issues, without hindsight [see Janssen Inc v Sandoz Canada Inc, 2022 FC 715 at para 71]. [90] Expert witnesses assist the Court by opining on the qualifications, relevant experience and knowledge of the Skilled Person and ......
-
Sandoz Canada Inc. v. Janssen Inc.
...PHARMACEUTICALS LTD. Respondents REASONS FOR JUDGMENT LOCKE J.A. I. Overview [1] This appeal concerns a decision of the Federal Court (2022 FC 715, per Justice Christine M. Pallotta) that dismissed allegations by the appellant, Sandoz Canada Inc., that Canadian Patent No. 2,659,770 (the Pat......
-
2023 Year In Review: Life Sciences In Canada
...decision ( 2002 SCC 77 ) and Eli Lilly v. Novopharm ( 2010 FCA 197 ). The Court of Appeal, in alignment with the Federal Court's ruling in 2022 FC 715, upheld that the utility of Janssen's CA2,659,770 combination patent (macitentan and a PDE5 inhibitor to treat pulmonary arterial hypertensi......
-
Promise Me No Promises? The Five-year Anniversary Of The Supreme Court's AstraZeneca Decision
...at paras 219, 240-241. 38. Aux Sable at paras 56-69. 39. Aux Sable at paras 74. 40. Eli Lilly v Apotex, 2020 FC 814. 41. Janssen v Sandoz, 2022 FC 715 at para 42. Seedlings v Pfizer, 2021 FCA 154. Read the original article on GowlingWLG.com The content of this article is intended to provide......
Get Started for Free
2 cases
-
UPL NA Inc. v. AgraCity Crop & Nutrition Ltd.
...date and adopt the proper temporal frame of reference to analyze the issues, without hindsight [see Janssen Inc v Sandoz Canada Inc, 2022 FC 715 at para 71]. [90] Expert witnesses assist the Court by opining on the qualifications, relevant experience and knowledge of the Skilled Person and ......
-
Sandoz Canada Inc. v. Janssen Inc.
...PHARMACEUTICALS LTD. Respondents REASONS FOR JUDGMENT LOCKE J.A. I. Overview [1] This appeal concerns a decision of the Federal Court (2022 FC 715, per Justice Christine M. Pallotta) that dismissed allegations by the appellant, Sandoz Canada Inc., that Canadian Patent No. 2,659,770 (the Pat......
4 firm's commentaries
-
2023 Year In Review: Life Sciences In Canada
...decision ( 2002 SCC 77 ) and Eli Lilly v. Novopharm ( 2010 FCA 197 ). The Court of Appeal, in alignment with the Federal Court's ruling in 2022 FC 715, upheld that the utility of Janssen's CA2,659,770 combination patent (macitentan and a PDE5 inhibitor to treat pulmonary arterial hypertensi......
-
Promise Me No Promises? The Five-year Anniversary Of The Supreme Court's AstraZeneca Decision
...at paras 219, 240-241. 38. Aux Sable at paras 56-69. 39. Aux Sable at paras 74. 40. Eli Lilly v Apotex, 2020 FC 814. 41. Janssen v Sandoz, 2022 FC 715 at para 42. Seedlings v Pfizer, 2021 FCA 154. Read the original article on GowlingWLG.com The content of this article is intended to provide......
-
Federal Court Finds Janssen's Macitentan Combination Therapy Patent Valid
...of Canadian Patent No. 2,659,770 (the 770 Patent) valid and granted a declaration of infringement: Janssen Inc v Sandoz Canada Inc, 2022 FC 715. Macitentan belongs to a class of drugs known as endothelin receptor antagonists (ERAs). Janssen markets macitentan in Canada for the treatment of ......
-
Can A Factual Precedent Bind Another Party?
...anyway. The reason? A factual finding from an earlier proceeding with different parties concerning the same prior art (Janssen v Sandoz, 2022 FC 715). Based on that decision, the Court concluded "[t]here has been a judicial determination, upheld on appeal" that the prior art does not teach ......
